Global Navigation
|
|
|
|
Thank you for visiting Otsuka Pharmaceutical Group Website. Otsuka Pharmaceutical is planning to sort out the contents of the current Otsuka Pharmaceutical Group Website in the following manner (due around August 31, 2010).
All contents about Otsuka Pharmaceutical will be included in the newly-opened English site of Otsuka Pharmaceutical Co., Ltd..
For acquiring information on Otsuka group companies, please visit Otsuka Holdings Co., Ltd.
- 23 JULY 2010
E Keppra® (levetiracetam) receives regulatory approval in Japan - 12 JULY 2010
SPRYCEL® (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase - 30 JUN 2010
GW and Otsuka Agree Three Year Extension to Global Cannabinoid Research Collaboration
- 10 JUNE 2010
Otsuka Pharmaceutical Co., Ltd. Appoints the Board Members and Statutory Auditors (PDF:39KB) - 31 MAR 2010
Novel Soy Germ-Based Dietary Supplement, SE5-OH Containing Natural S-equol, Examined for Safety and Influence on Hormones in Pre- and Post-Menopausal Women - 31 MAR 2010
First reader-participation collaboration OTSUKA Health Comic Library Sequel Vol. 3 “We Are Children of the Earth: The Environment & Our Health” March 31 publication for donation to elementary schools nationwide